Identification of Novel Potential VEGFR-2 Inhibitors Using a Combination of Computational Methods for Drug Discovery

The vascular endothelial growth factor receptor 2 (VEGFR-2) is largely recognized as a potent therapeutic molecular target for the development of angiogenesis-related tumor treatment. Tumor growth, metastasis and multidrug resistance highly depends on the angiogenesis and drug discovery of the poten...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Sanea, Mohammad M., Chilingaryan, Garri, Abelyan, Narek, Sargsyan, Arsen, Hovhannisyan, Sargis, Gasparyan, Hayk, Gevorgyan, Smbat, Albogami, Sarah, Ghoneim, Mohammed M., Farag, Ahmed K., Mohamed, Ahmed A. B., El-Damasy, Ashraf K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540634/
https://www.ncbi.nlm.nih.gov/pubmed/34685441
http://dx.doi.org/10.3390/life11101070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540634/
https://www.ncbi.nlm.nih.gov/pubmed/34685441
http://dx.doi.org/10.3390/life11101070

Ejemplares similares